Some analysts predict that the global wearable injectors market will reach US$18.3 billion by 2028. This growth is being driven by the benefits these devices deliver to various stakeholders. For Pharma and Biotech companies, wearables offer the opportunity to grow market share and reduce competition.

Worldwide, patient and provider preferences are changing due to the covid-19 pandemic. The need to reduce patient exposure to the virus and free up healthcare resources is driving unprecedented change. IoT technology brings new opportunities and can help us establish a new normal with use cases and innovation for healthcare, COVID-19 testing, building health and remote device maintenance.

The conference represents a unique opportunity for learning, exchanging opinions, and expanding one’s network enabled by live presentations followed by dynamic Q&A sessions – providing the attendees with valuable insights from specialists in the sphere of Medical device